107 related articles for article (PubMed ID: 12654635)
21. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
22. Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells.
Shimada K; Ozawa T
J Clin Invest; 1985 Apr; 75(4):1308-16. PubMed ID: 3157703
[TBL] [Abstract][Full Text] [Related]
23. Proteoglycan and glycosaminoglycan synthesis by cultured rat mesangial cells.
Groggel GC; Hovingh P; Linker A
J Cell Physiol; 1991 Jun; 147(3):455-9. PubMed ID: 1906068
[TBL] [Abstract][Full Text] [Related]
24. Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach.
Najjam S; Gibbs RV; Gordon MY; Rider CC
Cytokine; 1997 Dec; 9(12):1013-22. PubMed ID: 9417813
[TBL] [Abstract][Full Text] [Related]
25. CD44-chondroitin sulfate interactions mediate leukocyte rolling under physiological flow conditions.
Murai T; Sougawa N; Kawashima H; Yamaguchi K; Miyasaka M
Immunol Lett; 2004 May; 93(2-3):163-70. PubMed ID: 15158613
[TBL] [Abstract][Full Text] [Related]
26. Non-receptor-mediated tissue localization of human interferon-gamma: role of heparan sulfate/heparin-like molecules.
Lortat-Jacob H; Brisson C; Guerret S; Morel G
Cytokine; 1996 Jul; 8(7):557-66. PubMed ID: 8891437
[TBL] [Abstract][Full Text] [Related]
27. Incorporation of 35S-sulfate and 3H-glucosamine into heparan and chondroitin sulfates during the cell cycle of B16-F10 cells.
Blair OC; Sartorelli AC
Cytometry; 1984 May; 5(3):281-8. PubMed ID: 6234152
[TBL] [Abstract][Full Text] [Related]
28. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.
Kokenyesi R; Silbert JE
Biochem Biophys Res Commun; 1995 Jun; 211(1):262-7. PubMed ID: 7779094
[TBL] [Abstract][Full Text] [Related]
29. Foam cell conversion of macrophages alters the biosynthesis of heparan sulfate.
Ghiselli G; Lindahl U; Salmivirta M
Biochem Biophys Res Commun; 1998 Jun; 247(3):790-5. PubMed ID: 9647772
[TBL] [Abstract][Full Text] [Related]
30. Glycosaminoglycans in human lung carcinoma.
Hatae Y; Atsuta T; Makita A
Gan; 1977 Feb; 68(1):59-63. PubMed ID: 863174
[TBL] [Abstract][Full Text] [Related]
31. Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells.
Cheng F; Petersson P; Arroyo-Yanguas Y; Westergren-Thorsson G
J Cell Biochem; 2001; 83(4):597-606. PubMed ID: 11746503
[TBL] [Abstract][Full Text] [Related]
32. Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study.
Balbisi M; Sugár S; Schlosser G; Szeitz B; Fillinger J; Moldvay J; Drahos L; Szász AM; Tóth G; Turiák L
Sci Rep; 2023 Apr; 13(1):6268. PubMed ID: 37069213
[TBL] [Abstract][Full Text] [Related]
33. Binding of interleukin-8 to heparan sulphate enhances cervical maturation in rabbits.
Belayet HM; Kanayama N; Khatun S; Sumimoto K; Kobayashi T; Terao T
Mol Hum Reprod; 1999 Mar; 5(3):261-9. PubMed ID: 10333361
[TBL] [Abstract][Full Text] [Related]
34. Covalent modification of superoxide dismutase subunits by chondroitin sulfate.
Maksimenko AV; Tischenko EG
Biochemistry (Mosc); 1997 Oct; 62(10):1163-6. PubMed ID: 9461639
[TBL] [Abstract][Full Text] [Related]
35. Tissue-specific mechanisms control the retention of IL-8 in lungs and skin.
Frevert CW; Goodman RB; Kinsella MG; Kajikawa O; Ballman K; Clark-Lewis I; Proudfoot AE; Wells TN; Martin TR
J Immunol; 2002 Apr; 168(7):3550-6. PubMed ID: 11907118
[TBL] [Abstract][Full Text] [Related]
36. PEGylation of a glycosaminoglycan-binding, dominant-negative CXCL8 mutant retains bioactivity in vitro and in vivo.
Gerlza T; Trojacher C; Jeremic D; Krieger E; Adage T; Kungl A
Cytokine; 2020 Mar; 127():154942. PubMed ID: 31794956
[TBL] [Abstract][Full Text] [Related]
37. [Binding capacity of tissue proteins for chondroitin sulfate; a single histochemical protein reaction, especially for nervous tissue].
FRIEDE R
Virchows Arch Pathol Anat Physiol Klin Med; 1957; 330(5):574-6. PubMed ID: 13530673
[No Abstract] [Full Text] [Related]
38. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors.
Hoch RC; Schraufstätter IU; Cochrane CG
J Lab Clin Med; 1996 Aug; 128(2):134-45. PubMed ID: 8765209
[No Abstract] [Full Text] [Related]
39. Roles of extracellular matrix in lung diseases.
Tanino Y
Fukushima J Med Sci; 2024 Jan; 70(1):1-9. PubMed ID: 38267030
[TBL] [Abstract][Full Text] [Related]
40. KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment.
Carpenter ES; Kadiyala P; Elhossiny AM; Kemp SB; Li J; Steele NG; Nicolle R; Nwosu ZC; Freeman J; Dai H; Paglia D; Du W; Donahue K; Morales J; Medina-Cabrera PI; Bonilla ME; Harris L; The S; Gunchick V; Peterson N; Brown K; Mattea M; Espinoza CE; McGue J; Kabala SM; Baliira RK; Renollet NM; Mooney AG; Liu J; Bhalla S; Farida JP; Ko C; Machicado JD; Kwon RS; Wamsteker EJ; Schulman A; Anderson MA; Law R; Prabhu A; Coulombe PA; Rao A; Frankel TL; Bednar F; Shi J; Sahai V; Pasca Di Magliano M
Clin Cancer Res; 2024 Jun; 30(11):2497-2513. PubMed ID: 37851080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
